v3.25.4
Commitments and Contingencies, Type of Agreement (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 23, 2022
Jun. 15, 2022
Nov. 09, 2021
Apr. 10, 2019
Jun. 06, 2018
Dec. 31, 2025
Dec. 31, 2024
Type of Arrangement [Abstract]              
Research and development expense           $ 30,812 $ 26,851
LCA5/RDH12 Agreement [Member] | Development, Regulatory and Commercial Milestone [Member]              
Type of Arrangement [Abstract]              
Research and development expense           100  
LCA5/RDH12 Agreement [Member] | Development, Regulatory and Commercial Milestone [Member] | Maximum [Member]              
Type of Arrangement [Abstract]              
Milestone payments   $ 2,600          
Iveric Agreement [Member] | Commercial Milestones [Member] | BEST1 Program [Member]              
Type of Arrangement [Abstract]              
Research and development expense           400  
Iveric Agreement [Member] | Commercial Milestones [Member] | Maximum [Member] | BEST1 Program [Member]              
Type of Arrangement [Abstract]              
Milestone payments $ 111,700            
BEST1 License Agreement [Member] | Commercial Milestones [Member] | First Licensed Product [Member]              
Type of Arrangement [Abstract]              
Research and development expense           $ 700  
BEST1 License Agreement [Member] | Commercial Milestones [Member] | Maximum [Member] | First Licensed Product [Member]              
Type of Arrangement [Abstract]              
Milestone payments       $ 76,400      
Penn and UF RHO License Agreement [Member] | Development, Regulatory and Commercial Milestone [Member] | Maximum [Member]              
Type of Arrangement [Abstract]              
Milestone payments         $ 93,500    
Massachusetts Eye and Ear Infirmary License Agreement [Member] | Development, Regulatory and Commercial Milestone [Member] | Maximum [Member]              
Type of Arrangement [Abstract]              
Milestone payments     $ 400